Cargando…
Commentary: Single-use bevacizumab: The final solution?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508092/ https://www.ncbi.nlm.nih.gov/pubmed/32461440 http://dx.doi.org/10.4103/ijo.IJO_24_20 |
| _version_ | 1783585361019011072 |
|---|---|
| author | Narayanan, Raja |
| author_facet | Narayanan, Raja |
| author_sort | Narayanan, Raja |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7508092 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75080922020-10-02 Commentary: Single-use bevacizumab: The final solution? Narayanan, Raja Indian J Ophthalmol Commentary Wolters Kluwer - Medknow 2020-06 /pmc/articles/PMC7508092/ /pubmed/32461440 http://dx.doi.org/10.4103/ijo.IJO_24_20 Text en Copyright: © 2020 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Commentary Narayanan, Raja Commentary: Single-use bevacizumab: The final solution? |
| title | Commentary: Single-use bevacizumab: The final solution? |
| title_full | Commentary: Single-use bevacizumab: The final solution? |
| title_fullStr | Commentary: Single-use bevacizumab: The final solution? |
| title_full_unstemmed | Commentary: Single-use bevacizumab: The final solution? |
| title_short | Commentary: Single-use bevacizumab: The final solution? |
| title_sort | commentary: single-use bevacizumab: the final solution? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508092/ https://www.ncbi.nlm.nih.gov/pubmed/32461440 http://dx.doi.org/10.4103/ijo.IJO_24_20 |
| work_keys_str_mv | AT narayananraja commentarysingleusebevacizumabthefinalsolution |